
Monica A. Weingart
Examiner (ID: 2340)
| Most Active Art Unit | 2914 |
| Art Unit(s) | 2904, 2914, 2900, 2903, 2901 |
| Total Applications | 2416 |
| Issued Applications | 2384 |
| Pending Applications | 0 |
| Abandoned Applications | 32 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5374142
[patent_doc_number] => 20090311703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-17
[patent_title] => 'METHODS FOR IDENTIFYING FACTORS FOR DIFFERENTIATING DEFINITIVE ENDODERM'
[patent_app_type] => utility
[patent_app_number] => 12/476570
[patent_app_country] => US
[patent_app_date] => 2009-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 85
[patent_figures_cnt] => 85
[patent_no_of_words] => 43080
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20090311703.pdf
[firstpage_image] =>[orig_patent_app_number] => 12476570
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/476570 | Methods for identifying factors for differentiating definitive endoderm | Jun 1, 2009 | Issued |
Array
(
[id] => 5379379
[patent_doc_number] => 20090191218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-30
[patent_title] => 'DNA Vaccines And Methods For The Prevention Of Transplantation Rejection'
[patent_app_type] => utility
[patent_app_number] => 12/409351
[patent_app_country] => US
[patent_app_date] => 2009-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7615
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20090191218.pdf
[firstpage_image] =>[orig_patent_app_number] => 12409351
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/409351 | DNA Vaccines And Methods For The Prevention Of Transplantation Rejection | Mar 22, 2009 | Abandoned |
Array
(
[id] => 6521427
[patent_doc_number] => 20100203195
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'Process for Separating High Purity Germ and Bran from Corn'
[patent_app_type] => utility
[patent_app_number] => 12/369287
[patent_app_country] => US
[patent_app_date] => 2009-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4415
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20100203195.pdf
[firstpage_image] =>[orig_patent_app_number] => 12369287
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/369287 | Process for Separating High Purity Germ and Bran from Corn | Feb 10, 2009 | Abandoned |
Array
(
[id] => 6125638
[patent_doc_number] => 20110086089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-14
[patent_title] => 'USE OF P27KIP1 FOR THE PREVENTION AND TREATMENT OF HEART FAILURE'
[patent_app_type] => utility
[patent_app_number] => 12/866538
[patent_app_country] => US
[patent_app_date] => 2009-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 32217
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 32
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20110086089.pdf
[firstpage_image] =>[orig_patent_app_number] => 12866538
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/866538 | USE OF P27KIP1 FOR THE PREVENTION AND TREATMENT OF HEART FAILURE | Feb 5, 2009 | Abandoned |
Array
(
[id] => 6588822
[patent_doc_number] => 20100061997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-11
[patent_title] => 'Transgenic Non-Human Animals Expressing A Truncated Activin Type II Receptor'
[patent_app_type] => utility
[patent_app_number] => 12/361512
[patent_app_country] => US
[patent_app_date] => 2009-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 51770
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0061/20100061997.pdf
[firstpage_image] =>[orig_patent_app_number] => 12361512
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/361512 | Transgenic non-human animals expressing a truncated activin type II receptor | Jan 27, 2009 | Issued |
Array
(
[id] => 6467335
[patent_doc_number] => 20100190839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-29
[patent_title] => 'Telomere-Encoding Synthetic DNA Nanocircles, and Their Use for the Elongation of Telomere Repeats'
[patent_app_type] => utility
[patent_app_number] => 12/359448
[patent_app_country] => US
[patent_app_date] => 2009-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 14757
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20100190839.pdf
[firstpage_image] =>[orig_patent_app_number] => 12359448
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/359448 | Telomere-encoding synthetic DNA nanocircles, and their use for the elongation of telomere repeats | Jan 25, 2009 | Issued |
Array
(
[id] => 5355462
[patent_doc_number] => 20090186806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-23
[patent_title] => 'Truncated Activin Type II Receptor and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 12/360093
[patent_app_country] => US
[patent_app_date] => 2009-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 51770
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20090186806.pdf
[firstpage_image] =>[orig_patent_app_number] => 12360093
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/360093 | Truncated Activin Type II Receptor and Methods of Use | Jan 25, 2009 | Abandoned |
Array
(
[id] => 7778684
[patent_doc_number] => 20120041055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-16
[patent_title] => 'COMPOSITE POLYNUCLEIC ACID THERAPEUTICS'
[patent_app_type] => utility
[patent_app_number] => 12/359949
[patent_app_country] => US
[patent_app_date] => 2009-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5820
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20120041055.pdf
[firstpage_image] =>[orig_patent_app_number] => 12359949
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/359949 | COMPOSITE POLYNUCLEIC ACID THERAPEUTICS | Jan 25, 2009 | Abandoned |
Array
(
[id] => 6627469
[patent_doc_number] => 20100172951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-08
[patent_title] => 'Enhanced Medical Implant'
[patent_app_type] => utility
[patent_app_number] => 12/348280
[patent_app_country] => US
[patent_app_date] => 2009-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4155
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20100172951.pdf
[firstpage_image] =>[orig_patent_app_number] => 12348280
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/348280 | Enhanced Medical Implant | Jan 2, 2009 | Abandoned |
Array
(
[id] => 6527473
[patent_doc_number] => 20100212033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-19
[patent_title] => 'Novel ubiquitin lifases as therapeutic tragets'
[patent_app_type] => utility
[patent_app_number] => 12/317495
[patent_app_country] => US
[patent_app_date] => 2008-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 87
[patent_figures_cnt] => 87
[patent_no_of_words] => 41254
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20100212033.pdf
[firstpage_image] =>[orig_patent_app_number] => 12317495
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/317495 | Novel ubiquitin lifases as therapeutic tragets | Dec 21, 2008 | Abandoned |
Array
(
[id] => 8146465
[patent_doc_number] => 08163470
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-04-24
[patent_title] => 'Simulated 5-part differential leukocyte granules, the method for preparing the same and control products and calibrators comprising the same'
[patent_app_type] => utility
[patent_app_number] => 12/274070
[patent_app_country] => US
[patent_app_date] => 2008-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5706
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 199
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/163/08163470.pdf
[firstpage_image] =>[orig_patent_app_number] => 12274070
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/274070 | Simulated 5-part differential leukocyte granules, the method for preparing the same and control products and calibrators comprising the same | Nov 18, 2008 | Issued |
Array
(
[id] => 4629568
[patent_doc_number] => 08008460
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-30
[patent_title] => 'Polynucleotide fragments of an infectious human endogenous retrovirus'
[patent_app_type] => utility
[patent_app_number] => 12/261374
[patent_app_country] => US
[patent_app_date] => 2008-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13556
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 170
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/008/08008460.pdf
[firstpage_image] =>[orig_patent_app_number] => 12261374
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/261374 | Polynucleotide fragments of an infectious human endogenous retrovirus | Oct 29, 2008 | Issued |
Array
(
[id] => 6607656
[patent_doc_number] => 20100099127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-22
[patent_title] => 'SYSTEM AND METHOD FOR ACQUIRING AND STORING BIOLOGICAL SAMPLES'
[patent_app_type] => utility
[patent_app_number] => 12/255173
[patent_app_country] => US
[patent_app_date] => 2008-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 1895
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20100099127.pdf
[firstpage_image] =>[orig_patent_app_number] => 12255173
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/255173 | SYSTEM AND METHOD FOR ACQUIRING AND STORING BIOLOGICAL SAMPLES | Oct 20, 2008 | Abandoned |
Array
(
[id] => 6219985
[patent_doc_number] => 20100055080
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-04
[patent_title] => 'BIOADHESIVE DIRECTED SOMATIC CELL THERAPY'
[patent_app_type] => utility
[patent_app_number] => 12/204596
[patent_app_country] => US
[patent_app_date] => 2008-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 13666
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20100055080.pdf
[firstpage_image] =>[orig_patent_app_number] => 12204596
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/204596 | BIOADHESIVE DIRECTED SOMATIC CELL THERAPY | Sep 3, 2008 | Abandoned |
Array
(
[id] => 5337258
[patent_doc_number] => 20090053722
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'SDAD ASSAY AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/193505
[patent_app_country] => US
[patent_app_date] => 2008-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 18038
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20090053722.pdf
[firstpage_image] =>[orig_patent_app_number] => 12193505
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/193505 | SDAD ASSAY AND USES THEREOF | Aug 17, 2008 | Abandoned |
Array
(
[id] => 5342771
[patent_doc_number] => 20090181421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-16
[patent_title] => 'DIAGNOSIS OF FETAL ABNORMALITIES USING NUCLEATED RED BLOOD CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/172158
[patent_app_country] => US
[patent_app_date] => 2008-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13363
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20090181421.pdf
[firstpage_image] =>[orig_patent_app_number] => 12172158
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/172158 | DIAGNOSIS OF FETAL ABNORMALITIES USING NUCLEATED RED BLOOD CELLS | Jul 10, 2008 | Abandoned |
Array
(
[id] => 303472
[patent_doc_number] => 07534608
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-05-19
[patent_title] => 'Methods of producing pancreatic hormones'
[patent_app_type] => utility
[patent_app_number] => 12/167227
[patent_app_country] => US
[patent_app_date] => 2008-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 74
[patent_figures_cnt] => 114
[patent_no_of_words] => 80951
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/534/07534608.pdf
[firstpage_image] =>[orig_patent_app_number] => 12167227
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/167227 | Methods of producing pancreatic hormones | Jul 1, 2008 | Issued |
Array
(
[id] => 6178175
[patent_doc_number] => 20110178170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-21
[patent_title] => 'GRISEOFULVIN ANALOGUES FOR THE TREATMENT OF CANCER BY INHIBITION OF CENTROSOMAL CLUSTERING'
[patent_app_type] => utility
[patent_app_number] => 12/666730
[patent_app_country] => US
[patent_app_date] => 2008-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 16931
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20110178170.pdf
[firstpage_image] =>[orig_patent_app_number] => 12666730
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/666730 | GRISEOFULVIN ANALOGUES FOR THE TREATMENT OF CANCER BY INHIBITION OF CENTROSOMAL CLUSTERING | Jun 29, 2008 | Abandoned |
Array
(
[id] => 5349381
[patent_doc_number] => 20090004742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-01
[patent_title] => 'SELECTION OF ANTIGEN-SPECIFIC T CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/144318
[patent_app_country] => US
[patent_app_date] => 2008-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 2438
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20090004742.pdf
[firstpage_image] =>[orig_patent_app_number] => 12144318
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/144318 | SELECTION OF ANTIGEN-SPECIFIC T CELLS | Jun 22, 2008 | Abandoned |
Array
(
[id] => 5484910
[patent_doc_number] => 20090274675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-05
[patent_title] => 'Migraine tonic'
[patent_app_type] => utility
[patent_app_number] => 12/214563
[patent_app_country] => US
[patent_app_date] => 2008-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4076
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20090274675.pdf
[firstpage_image] =>[orig_patent_app_number] => 12214563
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/214563 | Migraine tonic | Jun 20, 2008 | Abandoned |